• Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Harrow Health Inc.

Headquarters: Nashville, TN, United States
Year Founded: 2018
Status: Public
Industry Sector: HealthTechnology
CEO: Mark L. Baum
Number Of Employees: 382
Enterprise Value: $1,377,307,455
PE Ratio: -47.84
Exchange/Ticker 1: NASDAQ:HROW
Exchange/Ticker 2: N/A
Latest Market Cap: $865,403,840

BioCentury | Nov 26, 2024
Politics, Policy & Law

Marty Makary’s turn in the spotlight

Trump’s FDA commissioner pick has complex, controversial history
BioCentury | Nov 23, 2024
Politics, Policy & Law

Trump 2.0 presents opportunities, threats

A clear understanding of threats and opportunities will be essential as the biopharma industry steps into the second Trump administration
BioCentury | Aug 3, 2023
Data Byte

July follow-on financings: argenx raised majority of month’s $2.1B total

Ten biopharmas raised a combined $2.1B in July, of which argenx was responsible for nearly $1.3B
BioCentury | May 18, 2018
Financial News

Imprimis spinout Surface raises $20M series A

BioCentury | May 15, 2018
Financial News

Imprimis spinout Surface raises $20M series A

BioCentury | Mar 30, 2017
Financial News

Imprimis completes registered public offering

BioCentury | Dec 22, 2016
Financial News

Imprimis completes private placement

Items per page:
1 - 8 of 8